{"id":2127,"date":"2026-06-12T18:54:14","date_gmt":"2026-06-12T16:54:14","guid":{"rendered":"https:\/\/www.oncovirlab.hr\/?page_id=2127"},"modified":"2026-06-12T19:43:55","modified_gmt":"2026-06-12T17:43:55","slug":"cicada","status":"publish","type":"page","link":"https:\/\/www.oncovirlab.hr\/en\/cervirvac\/","title":{"rendered":"CerVirVac"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

<\/br>\nCerVirVac<\/h1>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Znanstveni centar izvrsnosti za virusnu imunologiju cjepiva<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Primarna misija Centra izvrsnosti za istra\u017eivanje virusne imunologije i razvoj novih cjepiva (CerVirVac) bila je pove\u0107ati kapacitete za znanost i inovacije u podru\u010djima imunologije, virologije i vakcinologije povezivanjem temeljnih znanstvenih otkri\u0107a s naprednim pretklini\u010dkim modelima. Glavna postignu\u0107a CerVirVac-a pozitivno su ocijenjena kroz godi\u0161nja izvje\u0161\u0107a i dodatne stru\u010dne evaluacije.<\/span><\/p>

Ciljevi CerVirVac-a za drugo razdoblje financiranja su:<\/span><\/p>

  1. Ja\u010danje kapaciteta istra\u017eiva\u010da za provo\u0111enje vrhunskih istra\u017eivanja u podru\u010dju virusne imunologije, vakcinologije i novih imunoterapijskih pristupa.<\/span><\/li>
  2. Ja\u010danje suradnje s istaknutim znanstvenim institucijama u Europskoj uniji kroz zajedni\u010dke prijave na natje\u010daje za istra\u017eiva\u010dko financiranje, koje obuhva\u0107aju temeljna i primijenjena istra\u017eivanja, te poticanje mobilnosti i usavr\u0161avanja zaposlenika.<\/span><\/li>
  3. Maksimiziranje translacijskog potencijala, osobito za nova protutijela u antivirusnoj i protutumorskoj imunoterapiji, kroz suradnju s biotehnolo\u0161kom industrijom, prepoznavanje mogu\u0107nosti za iskori\u0161tavanje intelektualnog vlasni\u0161tva te optimizaciju prijenosa tehnologije.<\/span><\/li><\/ol>

    Glavne ciljne skupine projekta uklju\u010duju istra\u017eiva\u010de u akademskoj i znanstvenoj zajednici, zdravstveni sustav, biotehnolo\u0161ku industriju te \u0161iru javnost. U ovom prijedlogu opisane su projektne aktivnosti s naglaskom na revolucionarna znanstvena otkri\u0107a s translacijskim potencijalom, u korist biomedicinske znanosti, gospodarstva i dru\u0161tva.<\/span><\/p>

    Projekt CerVirVac (ref. br. PK.1.1.10.0006) financiran je bespovratnim sredstvima Europske unije iz programa Konkurentnost i kohezija na razdoblje od 3 godine (01\/2024 \u2013 12\/2026). Institucija prijavitelj je Medicinski fakultet Sveu\u010dili\u0161ta u Rijeci, a voditelj projekta je akademik Stipan Jonji\u0107.<\/span><\/p>

    Cjelokupni Oncovirlab tim (putem Centra za istra\u017eivanje i prijenos znanja u biotehnologiji Sveu\u010dili\u0161ta u Zagrebu) sudjeluje u projektu kao partnerska institucija.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t\t
    <\/div>
    <\/div><\/div><\/div>
    <\/div>
    <\/div><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t

    Istra\u017eiva\u010dki tim<\/span><\/h3>

    Dr. sc. Beata Halassy, glavni istra\u017eiva\u010d
    <\/span>Dr. sc. Dubravko For\u010di\u0107
    <\/span>Dr. sc. Jelena Ivan\u010di\u0107 Jele\u010dki
    <\/span>Dr. sc. Maja Lang Balija
    <\/span>Dr. sc. Maja Jagu\u0161i\u0107
    <\/span>Dr. sc. Tanja Ko\u0161uti\u0107 Gulija
    <\/span>Dr. sc. Tihana Kurtovi\u0107
    <\/span>Dr. sc. Sanja Mateljak Luka\u010devi\u0107
    <\/span>Dr. sc. Sanda Ravli\u0107<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t

    \u00a0<\/h3>

    Tehni\u010dko osoblje:<\/strong><\/p>

    Renata Jug
    <\/span>Vi\u0161njica \u0160aronja<\/span><\/p>

    Projektna administracija<\/strong><\/p>

    Gordana Bla\u017eekovi\u0107, dipl oec.<\/span><\/p>

    Podr\u0161ka transferu tehnologije:\u00a0<\/strong><\/p>

    Dr. sc. Vesna Gabelica Markovi\u0107<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

    \n\t\t\t\t<\/div>\n\t\t
    \n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

    CerVirVac Znanstveni centar izvrsnosti za virusnu imunologiju cjepiva Primarna misija Centra izvrsnosti za istra\u017eivanje virusne imunologije i razvoj novih cjepiva (CerVirVac) bila je pove\u0107ati kapacitete za znanost i inovacije u podru\u010djima imunologije, virologije i vakcinologije povezivanjem temeljnih znanstvenih otkri\u0107a s naprednim pretklini\u010dkim modelima. Glavna postignu\u0107a CerVirVac-a pozitivno su ocijenjena kroz godi\u0161nja izvje\u0161\u0107a i dodatne stru\u010dne […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-2127","page","type-page","status-publish","hentry"],"yoast_head":"\nCerVirVac<\/title>\n<meta name=\"description\" content=\"Otkrijte kako na\u0161 onkoliti\u010dki virusni pripravak ciljano napada tumorske stanice, pove\u0107ava u\u010dinkovitost terapije i unapre\u0111uje lije\u010denje raka.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.oncovirlab.hr\/en\/cicada\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CerVirVac\" \/>\n<meta property=\"og:description\" content=\"Otkrijte kako na\u0161 onkoliti\u010dki virusni pripravak ciljano napada tumorske stanice, pove\u0107ava u\u010dinkovitost terapije i unapre\u0111uje lije\u010denje raka.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.oncovirlab.hr\/en\/cicada\/\" \/>\n<meta property=\"og:site_name\" content=\"Centar za istra\u017eivanje i prijenos znanja u biotehnologiji\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-12T17:43:55+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":[\"WebPage\",\"MedicalWebPage\"],\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/cervirvac\\\/\",\"url\":\"https:\\\/\\\/www.oncovirlab.hr\\\/cervirvac\\\/\",\"name\":\"CerVirVac\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/en\\\/#website\"},\"datePublished\":\"2026-06-12T16:54:14+00:00\",\"dateModified\":\"2026-06-12T17:43:55+00:00\",\"description\":\"Otkrijte kako na\u0161 onkoliti\u010dki virusni pripravak ciljano napada tumorske stanice, pove\u0107ava u\u010dinkovitost terapije i unapre\u0111uje lije\u010denje raka.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/cervirvac\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.oncovirlab.hr\\\/cervirvac\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/cervirvac\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.oncovirlab.hr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CerVirVac\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.oncovirlab.hr\\\/en\\\/\",\"name\":\"Centar za istra\u017eivanje i prijenos znanja u biotehnologiji\",\"description\":\"Laboratorij za imunokemiju i biokemiju\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.oncovirlab.hr\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/en\\\/#organization\",\"name\":\"Centar za istra\u017eivanje i prijenos znanja u biotehnologiji\",\"url\":\"https:\\\/\\\/www.oncovirlab.hr\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.oncovirlab.hr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/cropped-Oncovirlab-Icon.webp\",\"contentUrl\":\"https:\\\/\\\/www.oncovirlab.hr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/cropped-Oncovirlab-Icon.webp\",\"width\":512,\"height\":512,\"caption\":\"Centar za istra\u017eivanje i prijenos znanja u biotehnologiji\"},\"image\":{\"@id\":\"https:\\\/\\\/www.oncovirlab.hr\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"CerVirVac","description":"Discover how our oncolytic viral preparation targets tumor cells, increases therapy efficacy, and advances cancer treatment.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.oncovirlab.hr\/en\/cicada\/","og_locale":"en_US","og_type":"article","og_title":"CerVirVac","og_description":"Otkrijte kako na\u0161 onkoliti\u010dki virusni pripravak ciljano napada tumorske stanice, pove\u0107ava u\u010dinkovitost terapije i unapre\u0111uje lije\u010denje raka.","og_url":"https:\/\/www.oncovirlab.hr\/en\/cicada\/","og_site_name":"Centar za istra\u017eivanje i prijenos znanja u biotehnologiji","article_modified_time":"2026-06-12T17:43:55+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":["WebPage","MedicalWebPage"],"@id":"https:\/\/www.oncovirlab.hr\/cervirvac\/","url":"https:\/\/www.oncovirlab.hr\/cervirvac\/","name":"CerVirVac","isPartOf":{"@id":"https:\/\/www.oncovirlab.hr\/en\/#website"},"datePublished":"2026-06-12T16:54:14+00:00","dateModified":"2026-06-12T17:43:55+00:00","description":"Discover how our oncolytic viral preparation targets tumor cells, increases therapy efficacy, and advances cancer treatment.","breadcrumb":{"@id":"https:\/\/www.oncovirlab.hr\/cervirvac\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.oncovirlab.hr\/cervirvac\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.oncovirlab.hr\/cervirvac\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.oncovirlab.hr\/"},{"@type":"ListItem","position":2,"name":"CerVirVac"}]},{"@type":"WebSite","@id":"https:\/\/www.oncovirlab.hr\/en\/#website","url":"https:\/\/www.oncovirlab.hr\/en\/","name":"Center for Research and Knowledge Transfer in Biotechnology","description":"Laboratory for Immunochemistry and Biochemistry","publisher":{"@id":"https:\/\/www.oncovirlab.hr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.oncovirlab.hr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.oncovirlab.hr\/en\/#organization","name":"Center for Research and Knowledge Transfer in Biotechnology","url":"https:\/\/www.oncovirlab.hr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.oncovirlab.hr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.oncovirlab.hr\/wp-content\/uploads\/2025\/09\/cropped-Oncovirlab-Icon.webp","contentUrl":"https:\/\/www.oncovirlab.hr\/wp-content\/uploads\/2025\/09\/cropped-Oncovirlab-Icon.webp","width":512,"height":512,"caption":"Centar za istra\u017eivanje i prijenos znanja u biotehnologiji"},"image":{"@id":"https:\/\/www.oncovirlab.hr\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.oncovirlab.hr\/en\/wp-json\/wp\/v2\/pages\/2127","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.oncovirlab.hr\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.oncovirlab.hr\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.oncovirlab.hr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.oncovirlab.hr\/en\/wp-json\/wp\/v2\/comments?post=2127"}],"version-history":[{"count":4,"href":"https:\/\/www.oncovirlab.hr\/en\/wp-json\/wp\/v2\/pages\/2127\/revisions"}],"predecessor-version":[{"id":2144,"href":"https:\/\/www.oncovirlab.hr\/en\/wp-json\/wp\/v2\/pages\/2127\/revisions\/2144"}],"wp:attachment":[{"href":"https:\/\/www.oncovirlab.hr\/en\/wp-json\/wp\/v2\/media?parent=2127"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}